![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, November 16, 2021 12:27:06 PM
With my limited DD at this time, it looks to me like a Brilaciden-Oral Mucositis ( B-OM) Phase 3 study is just a pipe dream at this point.
It's possible IPIX and/or IPIX + AlphaSigma (A/S) might be working on something, and there could be a PR or actual clinical trial filings any day now.
If that is the case, then IMO, this sell-off in IPIX is producing an insanely good "Fire-Sale Price" for buyers right now. (1)
However . . . it appears to me that"
We shareholders have NO EVIDENCE of an actual B-OM PIII Trial even being seriously considered - nothing more than a few stray sentences referencing the idea, buried in PRs of the COVID trials.
But we have No evidence of an actual "plan":
No PR has been issued specific to this trial, describing any sort of plan.
No filings for a B-OM PIII at clinicaltrials.gov.
AlphaSigma's R&D page is vague (and that is being kind).
No evidence of any sort of behind-the-scenes execution of a plan. For example :
___a) no evidence of clinics contacted, or any willing to publicly state their willingness to participate in trials.
___b) no evidence of ANY actual involvement of A/S in planning a trial (or some combination of IPIX + A/S + some other BP).
----------------------------------------
AlphaSigma:
(2) A/P Research Page: It says nothing about Brilaciden. Under "Gastroenterology" it says they have:
a) "5 Projects, three of which are in clinical development" and then they list: "Normix, Tixteller, Xifaxan (rifaximin) Fully developed by Alfasigma Indicated for Hepatic Encephalopaty, Traveler’s diarrhea, IBS."
b) and lower on the page: Rifaximin - is one of the most effective microbiome modifier on the market - Irritable Bowel Disease, Hepatic Encephalopathy
------------------------------
This above is the gist - there is more on the background of Oral Mucositis (the chemotherapy market is ENORMOUS and B looks like it could really make a HUGE difference in Quality of Life for patients - see the Full post on Reddit's IPIX subreddit
You don't need an Reddit account to read this post
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM